SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Daytrading Canadian stocks in Realtime

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Hamlin who wrote (20647)8/20/1999 11:52:00 AM
From: Kevin Hamlin  Read Replies (2) of 62347
 
A little further on GBL. GBL owns 41.7% of a U.S. biopharmaceutical call BioMartin. BioMartin went public on Nasdaq in July. (symbol BMRN) After settling out in the $14.00 U.S. range, BMRN tacked on $1.00 U.S. yesterday, and has added another dollar so far today.

I don't know what is causing the jump in BMRN. The only thing I've been able to find is that the FDA is reviewing one of their products which could give them market exclusivity for 7 years. Whether it's related to this or something else...not sure. Something though is obviously making the stock jump.

Regards,

Kevin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext